Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Safety results presented from the AMETHYST-DN study

Nov. 15, 2012

Novel dual NADPH oxidase inhibitor shows excellent safety/pharmacokinetic profile

Nov. 14, 2012

Novel biguanide inhibits cell proliferation and cyst growth of human ADPKD cells

Nov. 13, 2012

Auxilium seeks approval of new indication for Xiaflex in the U.S.

Nov. 9, 2012

Promising results reported from phase IIa trial of UISH-001

Nov. 8, 2012

Votubia obtains European approval for TSC-associated renal angiomyolipoma

Nov. 6, 2012

Keryx Biopharmaceuticals commences phase II study of Zerenex

Nov. 5, 2012

BAX B-01 shows promise in model of proliferative nephritis

Nov. 5, 2012

European Commission approves Cialis in new indication

Oct. 31, 2012

Dosing commences in phase Ib/IIa study of KD-020

Oct. 29, 2012

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...